DE10215908B4 - Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel - Google Patents

Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel Download PDF

Info

Publication number
DE10215908B4
DE10215908B4 DE10215908A DE10215908A DE10215908B4 DE 10215908 B4 DE10215908 B4 DE 10215908B4 DE 10215908 A DE10215908 A DE 10215908A DE 10215908 A DE10215908 A DE 10215908A DE 10215908 B4 DE10215908 B4 DE 10215908B4
Authority
DE
Germany
Prior art keywords
alkyl
alkenyl
coo
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10215908A
Other languages
German (de)
English (en)
Other versions
DE10215908A1 (de
Inventor
Elisabeth Dr. Defossa
Dieter Dr. Kadereit
Karl Dr. Schoenafinger
Thomas Dr. Klabunde
Hans-Joerg Dr. Burger
Andreas Dr. Herling
Karl-Ulrich Dr. Wendt
Erich von Dr. Roedern
Alfons Dr. Enhsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10215908A priority Critical patent/DE10215908B4/de
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Priority to HR20040931A priority patent/HRP20040931A2/hr
Priority to PCT/EP2003/003254 priority patent/WO2003084923A1/de
Priority to CA002481819A priority patent/CA2481819A1/en
Priority to RU2004133046/04A priority patent/RU2004133046A/ru
Priority to PL03371317A priority patent/PL371317A1/xx
Priority to AU2003232192A priority patent/AU2003232192A1/en
Priority to KR10-2004-7016149A priority patent/KR20040097332A/ko
Priority to JP2003582122A priority patent/JP4328212B2/ja
Priority to AT03745772T priority patent/ATE404532T1/de
Priority to DE50310320T priority patent/DE50310320D1/de
Priority to IL16424803A priority patent/IL164248A0/xx
Priority to HU0500203A priority patent/HUP0500203A2/hu
Priority to HK05107763.5A priority patent/HK1075650B/xx
Priority to MXPA04009239A priority patent/MXPA04009239A/es
Priority to BR0309130-9A priority patent/BR0309130A/pt
Priority to YUP-887/04A priority patent/RS88704A/sr
Priority to EP03745772A priority patent/EP1497263B1/de
Priority to CNB038082241A priority patent/CN1263734C/zh
Priority to NZ535833A priority patent/NZ535833A/xx
Priority to ARP030101246A priority patent/AR039402A1/es
Priority to TW092108055A priority patent/TW200401765A/zh
Priority to US10/410,892 priority patent/US7078404B2/en
Publication of DE10215908A1 publication Critical patent/DE10215908A1/de
Priority to ZA200407361A priority patent/ZA200407361B/xx
Priority to MA27903A priority patent/MA27195A1/fr
Priority to NO20044881A priority patent/NO20044881L/no
Application granted granted Critical
Publication of DE10215908B4 publication Critical patent/DE10215908B4/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE10215908A 2002-04-11 2002-04-11 Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel Expired - Fee Related DE10215908B4 (de)

Priority Applications (26)

Application Number Priority Date Filing Date Title
DE10215908A DE10215908B4 (de) 2002-04-11 2002-04-11 Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
BR0309130-9A BR0309130A (pt) 2002-04-11 2003-03-28 Derivados de acil-3-carboxifenil-uréia, processo para a sua preparação e sua aplicação
CA002481819A CA2481819A1 (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
RU2004133046/04A RU2004133046A (ru) 2002-04-11 2003-03-28 Производные ацил-3-карбоксифенилмочевины, способ их получения и их применение
PL03371317A PL371317A1 (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
AU2003232192A AU2003232192A1 (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
KR10-2004-7016149A KR20040097332A (ko) 2002-04-11 2003-03-28 아실-3-카복시페닐우레아 유도체, 이의 제조방법 및 용도
JP2003582122A JP4328212B2 (ja) 2002-04-11 2003-03-28 アシル−３−カルボキシフェニル尿素誘導体、その製造方法およびその使用
AT03745772T ATE404532T1 (de) 2002-04-11 2003-03-28 Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
DE50310320T DE50310320D1 (de) 2002-04-11 2003-03-28 Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
IL16424803A IL164248A0 (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
HU0500203A HUP0500203A2 (hu) 2002-04-11 2003-03-28 Acil-3-karboxi-fenil-karbamid-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HK05107763.5A HK1075650B (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
MXPA04009239A MXPA04009239A (es) 2002-04-11 2003-03-28 Derivados de acil-3-carboxifenilurea, procedimientos para su preparacion y su utilizacion.
HR20040931A HRP20040931A2 (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
YUP-887/04A RS88704A (sr) 2002-04-11 2003-03-28 Derivati acil-3-karboksifenil- karbamida, postupak za njihovu proizvodnju i njihova primena
PCT/EP2003/003254 WO2003084923A1 (de) 2002-04-11 2003-03-28 Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
CNB038082241A CN1263734C (zh) 2002-04-11 2003-03-28 酰基－3－羧基苯基脲衍生物、其制备方法及其应用
NZ535833A NZ535833A (en) 2002-04-11 2003-03-28 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
EP03745772A EP1497263B1 (de) 2002-04-11 2003-03-28 Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
ARP030101246A AR039402A1 (es) 2002-04-11 2003-04-09 Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico
TW092108055A TW200401765A (en) 2002-04-11 2003-04-09 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
US10/410,892 US7078404B2 (en) 2002-04-11 2003-04-10 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
ZA200407361A ZA200407361B (en) 2002-04-11 2004-09-14 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof.
MA27903A MA27195A1 (fr) 2002-04-11 2004-10-08 Derives d'acyl-3 -carboxyphenyluree, procedes pour les preparer et leur utilisation.
NO20044881A NO20044881L (no) 2002-04-11 2004-11-09 Acyl-3-karboksyfenylureaderivater, fremstillingsfremgangsmate og anvendelse derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10215908A DE10215908B4 (de) 2002-04-11 2002-04-11 Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
DE10215908A1 DE10215908A1 (de) 2003-11-06
DE10215908B4 true DE10215908B4 (de) 2005-08-18

Family

ID=28684936

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10215908A Expired - Fee Related DE10215908B4 (de) 2002-04-11 2002-04-11 Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
DE50310320T Expired - Lifetime DE50310320D1 (de) 2002-04-11 2003-03-28 Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50310320T Expired - Lifetime DE50310320D1 (de) 2002-04-11 2003-03-28 Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung

Country Status (23)

Country Link
EP (1) EP1497263B1 (https=)
JP (1) JP4328212B2 (https=)
KR (1) KR20040097332A (https=)
CN (1) CN1263734C (https=)
AR (1) AR039402A1 (https=)
AT (1) ATE404532T1 (https=)
AU (1) AU2003232192A1 (https=)
BR (1) BR0309130A (https=)
CA (1) CA2481819A1 (https=)
DE (2) DE10215908B4 (https=)
HR (1) HRP20040931A2 (https=)
HU (1) HUP0500203A2 (https=)
IL (1) IL164248A0 (https=)
MA (1) MA27195A1 (https=)
MX (1) MXPA04009239A (https=)
NO (1) NO20044881L (https=)
NZ (1) NZ535833A (https=)
PL (1) PL371317A1 (https=)
RS (1) RS88704A (https=)
RU (1) RU2004133046A (https=)
TW (1) TW200401765A (https=)
WO (1) WO2003084923A1 (https=)
ZA (1) ZA200407361B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL164249A0 (en) * 2002-04-11 2005-12-18 Aventis Pharma Gmbh Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
DE10306502B4 (de) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0632019A1 (en) * 1993-06-28 1995-01-04 Zeneca Limited Acylureas
WO2001094300A1 (de) * 2000-06-09 2001-12-13 Aventis Pharma Deutschland Gmbh Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA867420B (en) * 1985-09-30 1987-05-27 Union Carbide Corp Pesticidal 1-(4-aryloxyphenyl)-3-benzoyl urea compounds and process for preparation
FI974437A7 (fi) * 1995-06-06 1997-12-05 Pfizer Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
WO2000056707A1 (en) * 1999-03-24 2000-09-28 Sepracor, Inc. Diaryl thioethers, compositions and uses thereof
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
PE20021091A1 (es) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0632019A1 (en) * 1993-06-28 1995-01-04 Zeneca Limited Acylureas
WO2001094300A1 (de) * 2000-06-09 2001-12-13 Aventis Pharma Deutschland Gmbh Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Chem.Abstr. 136:37410 & WO 0194300 A1 *
Chemical Abstracts 107:115373 *
Chemical Abstracts 109:110042 *
Chemical Abstracts 133:252175 *
Chemical Abstracts 99:87843 *
WO 01/94300 A1 u. Chem.Abstr. 136:37410

Also Published As

Publication number Publication date
DE10215908A1 (de) 2003-11-06
BR0309130A (pt) 2005-02-01
CN1263734C (zh) 2006-07-12
AU2003232192A1 (en) 2003-10-20
WO2003084923A1 (de) 2003-10-16
TW200401765A (en) 2004-02-01
ATE404532T1 (de) 2008-08-15
RU2004133046A (ru) 2005-04-20
ZA200407361B (en) 2006-02-22
DE50310320D1 (de) 2008-09-25
RS88704A (sr) 2007-02-05
AR039402A1 (es) 2005-02-16
EP1497263A1 (de) 2005-01-19
NO20044881L (no) 2005-01-07
MA27195A1 (fr) 2005-01-03
JP2005522481A (ja) 2005-07-28
PL371317A1 (en) 2005-06-13
IL164248A0 (en) 2005-12-18
HRP20040931A2 (en) 2005-02-28
CA2481819A1 (en) 2003-10-16
HUP0500203A2 (hu) 2005-06-28
NZ535833A (en) 2006-03-31
JP4328212B2 (ja) 2009-09-09
HK1075650A1 (en) 2005-12-23
CN1646486A (zh) 2005-07-27
KR20040097332A (ko) 2004-11-17
EP1497263B1 (de) 2008-08-13
MXPA04009239A (es) 2005-01-25

Similar Documents

Publication Publication Date Title
EP1497262B1 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
EP1713803B1 (de) 7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1513800B1 (de) N-benzoylureido-zimts urederivate, verfahren zu deren herste llung und deren verwendung
EP1523471B1 (de) Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE10215908B4 (de) Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
DE102004004972B3 (de) Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102004004971B3 (de) Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel
DE10309929B4 (de) Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
DE10306502B4 (de) Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
DE10302452B4 (de) Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
DE102004004973A1 (de) 7-Phenylamino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10335092B3 (de) Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
EP1556339B1 (de) Carboxyalkoxy-substituierte acyl-carboxyphenyl-harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel
DE10306503A1 (de) Substituierte Benzoylureidophenyl-piperidin- und pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
DE102004033405A1 (de) 7-Phenylamino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

8364 No opposition during term of opposition
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20131101